Market Overview

From Earlier: UBS Downgrades Teva Pharmaceutical Industries Limited to Neutral

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for TEVA

DateFirmActionFromTo
Jan 2016Deutsche BankMaintainsBuy
Dec 2015Mizuho SecuritiesInitiates Coverage onBuy
Dec 2015Guggenheim SecuritiesUpgradesNeutralBuy

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: News Downgrades Analyst Ratings

 

Related Articles (TEVA)

Get Benzinga's Newsletters